Aspirin Market to grow at an impressive rate During the Forecast Period
Increasing use of aspirin as over
the counter medication is expected to drive the growth of India aspirin
market.
According to
TechSci Research report, “India Aspirin Market By Product Type
(Prescription v/s OTC), By Form (Tablet, Capsule, Solution), By Route of
Administration (Oral v/s Intravenous), By Source (In-House v/s Contract
Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By
Application (Cardiovascular Diseases, Pain, Fever, Arthritis, Others), By End
User (Children ≥14 years v/s Adults), By Company, By Region, Forecast &
Opportunities, FY2026”, the India aspirin market is
expected to grow at an impressive rate during the forecast period on account of
the use of aspirin for multiple purposes such as an analgesic, in fever, in
cardiovascular diseases, in rheumatoid arthritis for reducing swelling and
inflammation, among others. Additionally, the easy availability and low cost of
aspirin are expected to propel the market growth over the next few years.
Besides, proven safety and efficacy of aspirin have further increased its
demand. However, side-effects such as nausea, indigestion, irritation in
stomach, among others can hamper the market growth through FY2026. Moreover, in
certain cases serious side effects such as bruising, vomiting, stomach
bleeding, among others can be observed due to intake of aspirin. Also, aspirin
is not recommended for patients having peptic ulcers, hemophilia or any other
bleeding disorder, asthma, among others. Furthermore, patients who are allergic
to any NSAID such as ibuprofen are also not recommended to use and consume
aspirin. All these factors are expected to restrict the market growth over the
next few years.
Browse XX market data Tables and XX Figures spread
through XXX Pages and an in-depth TOC on " India Aspirin Market"
https://www.techsciresearch.com/report/india-aspirin-market/5130.html
The India
aspirin market is segmented based on product type, form, route of
administration, source, distribution channel, application, end user, company
and region. Based on form, the market can be fragmented into tablet, capsule
and solution. The tablet segment is expected to dominate the market during
forecast period. This can be ascribed to their durability, safety, efficacy in
delivering oral medications, cost-effectiveness, easy availability, among
others. Additionally, a single tablet can accommodate a higher dose of active
pharmaceutical ingredient (API) as compared to capsule. Based on distribution
channel, the market can be split into online and offline. The offline segment
is expected to dominate the market through FY2026. This can be ascribed to the
widespread network of pharmacies and drug stores where the drug is easily
available both as a prescription medicine and as an OTC drug. Based on
application, the market can be categorized into cardiovascular diseases, pain,
fever, arthritis and others. The pain segment is expected to dominate the
market owing to the widespread use of aspirin as a quick, effective and excellent
pain reliver. The cardiovascular diseases segment is expected to witness
significant growth during the forecast period. This can be attributed to the
use of aspirin in stroke prevention, blood thinning, among others.
Eli
Lilly and Company (India) Pvt. Ltd., AstraZeneca Pharma India Limited, The
Andhra Sugars Limited, Unnati Pharmaceuticals Pvt. Ltd., Taj Pharmaceuticals
Limited, Trumac Healthcare, Zydus Healthcare Ltd., Cipla Limited, Reckitt
Benckiser (India) Ltd, Natco Pharma Limited and others are some of the leading
players operating in India aspirin market. Companies operating in the market
are using organic strategies such as product launches, mergers and
collaborations to boost their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5130
Customers can
also request for 10% free customization on this report.
“India aspirin market is
expected to witness growth during the forecast period on account of its
versatility as an analgesic and prescription drug especially in case of
cardiovascular disorders and stroke prevention. Additionally, aspirin is one of
the most trusted over the counter drug that is available and present in the
market for more than 120 years. Furthermore, supportive government policies
such as the Pharma Vision 2020, scheme for establishing bulk drug parks and
launch of incentive scheme for indigenous manufacturing of 53 APIs in India of
which aspirin is one, is expected to create lucrative opportunities for the
market growth through FY2026.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based India management consulting firm.
“India Aspirin Market By Product Type
(Prescription v/s OTC), By Form (Tablet, Capsule, Solution), By Route of
Administration (Oral v/s Intravenous), By Source (In-House v/s Contract
Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By
Application (Cardiovascular Diseases, Pain, Fever, Arthritis, Others), By End
User (Children ≥14 years v/s Adults), By Company, By Region, Forecast &
Opportunities, FY2026”, has evaluated
the future growth potential of India aspirin market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges and
opportunities in India aspirin market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]